GSK plc

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 09:05:24 11/06/2026 pm IST			5-day change	1st Jan Change
1,962.50 ^GBX	+2.13%		+3.18%	+7.56%

11:32am	Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal	RE
10/06	Intron Health Upgrades GSK to Hold Rating, Lifts PT	MT

GSK : Deutsche Bank is Neutral

Published on 06/08/2026 at 04:44 pm IST

MarketScreener with dpa-AFX Analyser

GSK PLC

+2.13%

Emmanuel Papadakis from Deutsche Bank retains his Neutral opinion on the stock. The target price is still set at GBX 1900.

Latest news about GSK plc

11:32am	Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal	RE
10/06	Intron Health Upgrades GSK to Hold Rating, Lifts PT	MT
10/06	European Midday Briefing : Shares Mixed as Geopolitical Tensions Rise	DJ
10/06	GSK plc, Nuvalent, Inc. - M&A Call
10/06	GSK : Deutsche Bank reiterates its Neutral rating	ZD
10/06	GSK : UBS sticks Neutral	ZD
10/06	Health Care Up Amid Multibillion Dollar Oncology Deals - Health Care Roundup	DJ
10/06	Nuvalent Acquisition Fairly Valued, Competing Bid Seen as Unlikely, Wedbush Says	MT
09/06	Gsk plc Announces Board and Committee Changes	CI
09/06	UK's FTSE 100 hits over three-week low as banks, energy stocks sag	RE
09/06	FTSE 100 down as Asia-focused financials struggle	AN
09/06	British Shares Fall Back Amid Renewed Peace Talks; GSK to Buy Nuvalent	MT
09/06	Top Midday Stories: GSK to Acquire Nuvalent for $10.6 Billion in Cash; Apple Introduces Siri AI, But EU Launch to be Delayed	MT
09/06	JM Smucker Moves on Profit Beat; Vail Resorts Down on Full Year Guidance Cut \| Stock Movers	MT
09/06	Global markets live: Apple, Intel, GE Aerospace, Airbus…

GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).

Employees

66,841

Sector

Pharmaceuticals

Calendar

Earnings release - Q2 2026

More about the company